List of Excipients in API glycopyrrolate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing glycopyrrolate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | CITRIC ACID MONOHYDRATE | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | GLYCERIN | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | METHYLPARABEN | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | PROPYLENE GLYCOL | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | PROPYLPARABEN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing glycopyrrolate
Detailed excipient profiles for glycopyrrolate
Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
glycopyrrolate drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | glycopyrrolate and formoterol fumarate | 0310-4600 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
glycopyrrolate drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | glycopyrrolate | 62135-961 |
| Granules Pharmaceuticals Inc | glycopyrrolate | 70010-106 |
| Saptalis Pharmaceuticals LLC | glycopyrrolate | 71656-061 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
glycopyrrolate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | glycopyrrolate | 16571-743 |
| AvKARE | glycopyrrolate | 42291-303 |
| Dr Reddy's Laboratories Limited | glycopyrrolate | 55111-648 |
| Ranbaxy Pharmaceuticals Inc | glycopyrrolate | 63304-210 |
| Excellium Pharmaceutical Inc | glycopyrrolate | 64125-139 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
glycopyrrolate drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Nexgen Pharma Inc | glycopyrrolate | 0722-7097 |
| Carwin Pharmaceutical Associates LLC | glycopyrrolate | 15370-160 |
| Alembic Labs LLC | glycopyrrolate | 15955-305 |
| AvKARE | glycopyrrolate | 42291-303 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
glycopyrrolate drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| Henry Schein Inc | glycopyrrolate | 0404-9777 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing BENZYL ALCOHOL
Excipient focus: CALCIUM CHLORIDE
glycopyrrolate drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | glycopyrrolate and formoterol fumarate | 0310-4600 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
glycopyrrolate drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Alembic Labs LLC | glycopyrrolate | 15955-305 |
| Rising Pharmaceuticals Inc | glycopyrrolate | 64980-258 |
| Carilion Materials Management | glycopyrrolate | 68151-0614 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
glycopyrrolate drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
glycopyrrolate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PYROPHOSPHATE
glycopyrrolate drug variants containing CALCIUM PYROPHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Nexgen Pharma Inc | glycopyrrolate | 0722-7097 |
| Carwin Pharmaceutical Associates LLC | glycopyrrolate | 15370-160 |
| Nuro Pharma Inc | glycopyrrolate | 59547-210 |
| Foxland Pharmaceuticals Inc | glycopyrrolate | 69067-050 |
| FH2 Pharma LLC | glycopyrrolate | 72887-160 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing CALCIUM PYROPHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
glycopyrrolate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | glycopyrrolate | 60429-665 |
| Stason Pharmaceuticals Inc | glycopyrrolate | 60763-475 |
| Rising Pharmaceuticals Inc | glycopyrrolate | 64980-258 |
| Quinn Pharmaceuticals | glycopyrrolate | 69076-475 |
| REMEDYREPACK INC | glycopyrrolate | 70518-3152 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
glycopyrrolate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| Holopack Verpackungstechnik GmbH | glycopyrrolate | 60940-024 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
glycopyrrolate drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Labs LLC | glycopyrrolate | 15955-305 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
glycopyrrolate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | glycopyrrolate | 68788-8650 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
glycopyrrolate drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | glycopyrrolate | 0904-6709 |
| Aurolife Pharma LLC | glycopyrrolate | 13107-014 |
| Par Formulations Private Limited | glycopyrrolate | 43227-065 |
| AvPAK | glycopyrrolate | 50268-363 |
| American Health Packaging | glycopyrrolate | 60687-458 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
glycopyrrolate drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| Chartwell RX LLC | glycopyrrolate | 62135-961 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
glycopyrrolate drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| Henry Schein Inc | glycopyrrolate | 0404-9777 |
| Henry Schein Inc | glycopyrrolate | 0404-9782 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9867 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
glycopyrrolate drug variants containing LACTOSE
glycopyrrolate drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
glycopyrrolate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Aurolife Pharma LLC | glycopyrrolate | 13107-014 |
| Rising Pharma Holdings Inc | glycopyrrolate | 16571-743 |
| AvPAK | glycopyrrolate | 50268-363 |
| Dr Reddy's Laboratories Limited | glycopyrrolate | 55111-648 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
glycopyrrolate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| NCS HealthCare of KY Inc dba Vangard Labs | glycopyrrolate | 0615-8170 |
| Nexgen Pharma Inc | glycopyrrolate | 0722-7097 |
| Major Pharmaceuticals | glycopyrrolate | 0904-6709 |
| Aurolife Pharma LLC | glycopyrrolate | 13107-014 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
glycopyrrolate drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Endo USA Inc | glycopyrrolate | 49884-042 |
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
glycopyrrolate drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: NORFLURANE
glycopyrrolate drug variants containing NORFLURANE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | glycopyrrolate and formoterol fumarate | 0310-4600 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing NORFLURANE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
glycopyrrolate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | glycopyrrolate | 0615-8170 |
| Nexgen Pharma Inc | glycopyrrolate | 0722-7097 |
| Major Pharmaceuticals | glycopyrrolate | 0904-6709 |
| Aurolife Pharma LLC | glycopyrrolate | 13107-014 |
| Carwin Pharmaceutical Associates LLC | glycopyrrolate | 15370-160 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
glycopyrrolate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
glycopyrrolate drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Par Formulations Private Limited | glycopyrrolate | 43227-065 |
| Nuro Pharma Inc | glycopyrrolate | 59547-210 |
| Bryant Ranch Prepack | glycopyrrolate | 63629-5442 |
| Rising Pharmaceuticals Inc | glycopyrrolate | 64980-272 |
| Carilion Materials Management | glycopyrrolate | 68151-0614 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
glycopyrrolate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| Chartwell RX LLC | glycopyrrolate | 62135-961 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
glycopyrrolate drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| Chartwell RX LLC | glycopyrrolate | 62135-961 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
glycopyrrolate drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| Chartwell RX LLC | glycopyrrolate | 62135-961 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
glycopyrrolate drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Saptalis Pharmaceuticals LLC | glycopyrrolate | 71656-061 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
glycopyrrolate drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Exela Pharma Sciences LLC | glycopyrrolate | 51754-6015 |
| Holopack Verpackungstechnik GmbH | glycopyrrolate | 60940-024 |
| Sunovion Pharmaceuticals Inc | glycopyrrolate | 63402-201 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
glycopyrrolate drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Saptalis Pharmaceuticals LLC | glycopyrrolate | 71656-061 |
| Novadoz Pharmaceuticals LLC | glycopyrrolate | 72205-070 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
glycopyrrolate drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9870 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0641-6212 |
| Sandoz Inc | glycopyrrolate | 0781-3825 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
glycopyrrolate drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Intra-Sana Laboratories | glycopyrrolate | 80056-160 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
glycopyrrolate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| NCS HealthCare of KY Inc dba Vangard Labs | glycopyrrolate | 0615-8170 |
| Nexgen Pharma Inc | glycopyrrolate | 0722-7097 |
| Major Pharmaceuticals | glycopyrrolate | 0904-6709 |
| Aurolife Pharma LLC | glycopyrrolate | 13107-014 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
glycopyrrolate drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Granules Pharmaceuticals Inc | glycopyrrolate | 70010-106 |
| Novadoz Pharmaceuticals LLC | glycopyrrolate | 72205-070 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| Henry Schein Inc | glycopyrrolate | 0404-9776 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION
glycopyrrolate drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | glycopyrrolate | 62135-961 |
| Saptalis Pharmaceuticals LLC | glycopyrrolate | 71656-061 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
glycopyrrolate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Stason Pharmaceuticals Inc | glycopyrrolate | 60763-475 |
| Bryant Ranch Prepack | glycopyrrolate | 71335-1225 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
glycopyrrolate drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | glycopyrrolate | 60429-665 |
| Quinn Pharmaceuticals | glycopyrrolate | 69076-475 |
| REMEDYREPACK INC | glycopyrrolate | 70518-3152 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: STRAWBERRY
glycopyrrolate drug variants containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing STRAWBERRY
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
glycopyrrolate drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| Aurobindo Pharma Limited | glycopyrrolate | 59651-435 |
| Chartwell RX LLC | glycopyrrolate | 62135-961 |
| Granules Pharmaceuticals Inc | glycopyrrolate | 70010-106 |
| NorthStar RxLLC | glycopyrrolate | 72603-240 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
glycopyrrolate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9587 |
| Hikma Pharmaceuticals USA Inc | glycopyrrolate | 0143-9682 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Henry Schein Inc | glycopyrrolate | 0404-9775 |
| >Company | >Ingredient | >NDC |
glycopyrrolate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| NCS HealthCare of KY Inc dba Vangard Labs | glycopyrrolate | 0615-8170 |
| Nexgen Pharma Inc | glycopyrrolate | 0722-7097 |
| Major Pharmaceuticals | glycopyrrolate | 0904-6709 |
| Aurolife Pharma LLC | glycopyrrolate | 13107-014 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
